HemaCare Now on OTC Marginable Stock List
- Share via
HemaCare Corp. in Sherman Oaks said that the Board of Governors of the Federal Reserve System has approved HemaCare for listing on the Over-the-Counter Marginable Stock List, beginning Aug. 10.
The listing will give HemaCare investors the ability to buy HemaCare stock on margin--in other words, with borrowed money--and use the stock as collateral for the loan used to buy the stock.
HemaCare is a provider of blood-related products and services.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.